Metastatic disease to the hip and pelvis: Surgical management

Producción científica: Articlerevisión exhaustiva

4 Citas (Scopus)

Resumen

Metastatic disease to the pelvis and lower extremity is a significant contributor to morbidity in patients with metastatic cancer. When indicated, surgical prevention of pathologic fractures and treatment of established fractures can preserve patient mobility, dramatically increase pain control, and prevent associated co-morbidities. Forty percent of bony metastases occur in the pelvis and 25% in the femur. Because of the limited life expectancy and debilitated nature of patients undergoing palliative surgery for metastatic disease, the surgical construct should allow immediate unrestricted weight bearing. All areas of the bone should be imaged and all significantly involved portions of the bone should be addressed with the reconstruction. Postoperative radiation therapy should be considered. With appropriate technique and implant selection, outcomes of surgical management are generally very good.

Idioma originalEnglish (US)
Páginas (desde-hasta)78-87
Número de páginas10
PublicaciónTechniques in Orthopaedics
Volumen22
N.º2
DOI
EstadoPublished - jun 2007
Publicado de forma externa

ASJC Scopus subject areas

  • Orthopedics and Sports Medicine

Huella

Profundice en los temas de investigación de 'Metastatic disease to the hip and pelvis: Surgical management'. En conjunto forman una huella única.

Citar esto